Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Conditions:   T-cell Lymphoma;   Cutaneous/Peripheral T-Cell Lymphoma;   Peripheral T-cell Lymphoma;   Peripheral T-Cell Lymphoma, Not Classified;   Primary Cutaneous T-cell Lymphoma;   Cutaneous T-Cell Lymphoma, Unspecified;   Cutaneous T-cell Lymphoma;   Follicular T-Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Sézary's Disease;   Mycosis Fungoides Intervention:   Drug: Fenretinide Sponsors:   SciTech Development, LLC;   Rush University Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials